{
    "2018-02-28": [
        [
            {
                "time": "",
                "original_text": "医疗保健：以业绩为导向 荐8股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "业绩",
                        "荐股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：业绩兑现期 围绕一致性评价及业绩超预期精选标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩兑现",
                        "一致性评价",
                        "精选标的"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强烈推荐评级]智飞生物(300122)：2017年业绩基本符合预期 静待四价HPV疫苗放量",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2017年业绩",
                        "四价HPV疫苗",
                        "放量"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【晨会聚焦】军工板块关注度提高",
                "features": {
                    "keywords": [
                        "军工板块",
                        "关注度提高"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "军工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药-智飞生物(300122)】江琦、赵磊（联系人）：公司点评：业绩快速增长，看好2018年HPV疫苗和三联苗销售-0227",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩快速增长",
                        "HPV疫苗",
                        "三联苗",
                        "销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}